Correlation Between Editas Medicine and Pulmatrix

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Editas Medicine and Pulmatrix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Editas Medicine and Pulmatrix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Editas Medicine and Pulmatrix, you can compare the effects of market volatilities on Editas Medicine and Pulmatrix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Editas Medicine with a short position of Pulmatrix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Editas Medicine and Pulmatrix.

Diversification Opportunities for Editas Medicine and Pulmatrix

-0.82
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Editas and Pulmatrix is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding Editas Medicine and Pulmatrix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pulmatrix and Editas Medicine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Editas Medicine are associated (or correlated) with Pulmatrix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pulmatrix has no effect on the direction of Editas Medicine i.e., Editas Medicine and Pulmatrix go up and down completely randomly.

Pair Corralation between Editas Medicine and Pulmatrix

Given the investment horizon of 90 days Editas Medicine is expected to under-perform the Pulmatrix. But the stock apears to be less risky and, when comparing its historical volatility, Editas Medicine is 1.4 times less risky than Pulmatrix. The stock trades about -0.11 of its potential returns per unit of risk. The Pulmatrix is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  178.00  in Pulmatrix on November 2, 2024 and sell it today you would earn a total of  592.00  from holding Pulmatrix or generate 332.58% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Editas Medicine  vs.  Pulmatrix

 Performance 
       Timeline  
Editas Medicine 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Editas Medicine has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Pulmatrix 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Pulmatrix are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of very weak essential indicators, Pulmatrix displayed solid returns over the last few months and may actually be approaching a breakup point.

Editas Medicine and Pulmatrix Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Editas Medicine and Pulmatrix

The main advantage of trading using opposite Editas Medicine and Pulmatrix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Editas Medicine position performs unexpectedly, Pulmatrix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pulmatrix will offset losses from the drop in Pulmatrix's long position.
The idea behind Editas Medicine and Pulmatrix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
CEOs Directory
Screen CEOs from public companies around the world
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing